TP53 and neoplasm: Additionally, the cohort analysis identified pairs with significant co-occurrence, including KRAS and APC, TP53 and APC, KRAS and CDKN2A, KRAS and STK11, KRAS, KEAP1, and SMARCA4 and KEAP1, highlighting the importance of these oncogenes in CUP tumours.